Intravenously Administered Novel Liposomes, DCL64, Deliver Oligonucleotides to Cerebellar Purkinje Cells
出版年份 2018 全文链接
标题
Intravenously Administered Novel Liposomes, DCL64, Deliver Oligonucleotides to Cerebellar Purkinje Cells
作者
关键词
Blood-brain barrier, Liposomes, Low-density lipoprotein receptor, Oligonucleotide, Purkinje cells, Spinocerebellar ataxias
出版物
CEREBELLUM
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-07-09
DOI
10.1007/s12311-018-0961-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oligonucleotide therapy mitigates disease in Spinocerebellar Ataxia Type 3 mice
- (2018) Hayley S. McLoughlin et al. ANNALS OF NEUROLOGY
- Use of Nanoparticles for Cerebral Cancer
- (2018) Jörg Kreuter et al. TUMORI
- Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
- (2017) Daniel R. Scoles et al. NATURE
- RNAi prevents and reverses phenotypes induced by mutant human ataxin-1
- (2016) Megan S. Keiser et al. ANNALS OF NEUROLOGY
- Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury
- (2016) Igor Khalin et al. DRUG DELIVERY
- Role of scavenger receptors in peptide-based delivery of plasmid DNA across a blood–brain barrier model
- (2016) Artita Srimanee et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron
- (2016) Yu Miyazaki et al. Science Translational Medicine
- Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3
- (2016) Lodewijk J. A. Toonen et al. Scientific Reports
- Synthetic Nucleic Acids and Treatment of Neurological Diseases
- (2016) David R. Corey JAMA Neurology
- Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles
- (2015) Lei Wang et al. JOURNAL OF DRUG TARGETING
- Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study
- (2015) Heike Jacobi et al. LANCET NEUROLOGY
- Peptide-like Polymers Exerting Effective Glioma-Targeted siRNA Delivery and Release for Therapeutic Application
- (2015) Sai An et al. Small
- Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas
- (2014) Zhen-Zhen Yang et al. BIOMATERIALS
- Nonallele Specific Silencing of Ataxin-7 Improves Disease Phenotypes in a Mouse Model of SCA7
- (2014) Pavitra S Ramachandran et al. MOLECULAR THERAPY
- Consensus Paper: Pathological Mechanisms Underlying Neurodegeneration in Spinocerebellar Ataxias
- (2013) A. Matilla-Dueñas et al. CEREBELLUM
- Adsorption of plasma proteins on uncoated PLGA nanoparticles
- (2013) Karim Sempf et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice
- (2013) Edgardo Rodríguez-Lebrón et al. MOLECULAR THERAPY
- Clinical Neurogenetics
- (2013) Vikram G. Shakkottai et al. NEUROLOGIC CLINICS
- Liposomes to Target Peripheral Neurons and Schwann Cells
- (2013) Sooyeon Lee et al. PLoS One
- An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases
- (2012) Agnieszka Fiszer et al. BMC MOLECULAR BIOLOGY
- Transgenic Models of Spinocerebellar Ataxia Type 10: Modeling a Repeat Expansion Disorder
- (2012) Karen N. McFarland et al. Genes
- Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: A toxic RNA gain-of-function model
- (2011) Misti White et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Efficient In Vivo Delivery of siRNA Into Brain Capillary Endothelial Cells Along With Endogenous Lipoprotein
- (2011) Hiroya Kuwahara et al. MOLECULAR THERAPY
- Transport across the Blood-Brain Barrier of Pluronic Leptin
- (2010) T. O. Price et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters
- (2009) Svetlana Gelperina et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Delivery of small-interfering RNA (siRNA) to the brain
- (2009) Saroj P Mathupala EXPERT OPINION ON THERAPEUTIC PATENTS
- Macromolecular drug transport into the brain using targeted therapy
- (2009) Jacek Lichota et al. JOURNAL OF NEUROCHEMISTRY
- Safety Assessment of Poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, Poloxamer 105 Benzoate, and Poloxamer 182 Dibenzoate as Used in Cosmetics
- (2008) INTERNATIONAL JOURNAL OF TOXICOLOGY
- Novel Therapeutic Modalities to Address Nondrugable Protein Interaction Targets
- (2008) Errol B De Souza et al. NEUROPSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started